Oncology Activation & Omnichannel Leader

Jazz Pharmaceuticals; United States; Remote; USD 189,000 - 283,000; Full time

Job summary

Jazz Pharmaceuticals is seeking a senior Marketing and Omnichannel leader to anchor the Global Capability Product Teams, representing the Oncology Franchise and embedding new capability products across the function.

This role emphasizes driving adoption, change management, and cross-functional leadership to translate strategy into measurable outcomes, with 20-25% travel and US-based eligibility.

Qualifications

• Bachelor’s degree required; advanced degree preferred.
• 10 years’ minimum work experience in Marketing, Omnichannel or Activation roles.
• Proven ability to lead activation initiatives, translate strategy into execution and drive measurable outcomes.
• Understanding of Product Operating Model and agile methods.
• Formal training or hands-on experience in organizational change management.
• Proficiency in analyzing adoption, utilization, and performance data to derive insights.
• Exceptional communication and storytelling skills; able to translate complex capability concepts into simple narratives.

Responsibilities

• Represent the Oncology Franchise to Global Capability Product Teams.
• Embed new Global Capability Products in the ways of working across the Oncology Franchise.
• Catalyze and support Omnichannel Orchestration execution—planning, alignment, and impact measurement.

Skills

Marketing

Omnichannel

Activation

Change management

Storytelling

Cross-functional leadership

Agile methods

Education

Bachelor's degree

Advanced degree preferred

Tools

CRM systems

Journey orchestration

Marketing automation

Digital engagement tools

Job description

Jazz Pharmaceuticals is seeking a senior Marketing and Omnichannel leader to anchor the Global Capability Product Teams, representing the Oncology Franchise and embedding new capability products across the function.

This role emphasizes driving adoption, change management, and cross-functional leadership to translate strategy into measurable outcomes, with 20-25% travel and US-based eligibility.